The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

In his interview with Easton Jr., Dawkins discussed representing Boehringer & Lilly’s It Takes 2 health initiative, spreading ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

We recently compiled a list of the Tech Billionaire Chase Coleman’s Top 10 Stock Picks. In this article, we are going to take ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Determined to find out who was naughty or nice this year, Santa Claus visited the Penn Cambria School District last week in ...

Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Action superstar Sylvester Stallone pulled plans for a proposed seaweed barrier next to his home, after hearing concerns from ...

"At a time when Israel is fighting on seven fronts, we deeply appreciate the steadfast support of our Christian friends around the world," Netanyahu said. Information ...